PBAC Public Summary Documents – September 2021 meeting (first time rejections and deferrals)

14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...

Read more →

Updated agenda for the March 2022 PBAC meeting

5 January 2022 - The agenda for the March 2022 PBAC meeting has been updated.  ...

Read more →

Schedule of Pharmaceutical Benefits - 1 January 2022 update

1 January 2022 - The January 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

PBS listing for Braftovi and cetuximab for metastatic bowel cancer patients with BRAFV600 mutation

30 December 2021 - Pierre Fabre Australia today announced that Braftovi (encorafenib) in combination with cetuximab will be listed on the ...

Read more →

Public Summary Documents – September 2021 PBAC meeting

24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...

Read more →

PBS expenditure and prescriptions report 2020-21

24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...

Read more →

Report on the collection of under co-payment data 2020-21

24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...

Read more →

Extension to image based prescription special arrangement

22 December 2021 - The Department of Health has extended the ‘image based prescription’ interim measure which allows the supply of ...

Read more →

New treatment for heart failure to support thousands of Australian patients

20 December 2021 - From 1 January 2022, tens of thousands of Australians with symptomatic heart failure will have access to ...

Read more →

Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer

17 December 2021 - Prostate Cancer Foundation of Australia has welcomed recommendations by Australia’s Pharmaceutical Benefits Advisory Committee to list ...

Read more →

Recommendations made by the PBAC - November 2021

17 December 2021 - The recommendations from the November 2021 PBAC meeting are now available. ...

Read more →

Australia launches National Preventive Health Strategy

13 December 2021 - The Australian Government has today launched the National Preventive Health Strategy, a 10 year plan to improve ...

Read more →

Price disclosure 2022 April cycle outcomes summary

10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...

Read more →

Biosimilar follitropin alfa on the PBS - information for health care professionals and patients

7 December 2021 - A biosimilar brand of follitropin alfa (Ovaleap) was listed on the PBS on 1 December 2021.  ...

Read more →

PBS in review (2021)

5 December 2021 - We review the new medicines listed on the PBS in 2021. ...

Read more →